Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Contributions to Global Hematology from Low and Middle-Income Countries: Insights from ASH 2018

Andrés Gómez-De León, MD, Perla R. Colunga Pedraza, MD, Luz del Carmen Tarín Arzaga, MD, Emmanuel Bugarin-Estrada, MD, David Gómez-De León, Lillian Sung, MD PhD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 2123.

https://doi.org/10.1182/blood-2019-130053

Published: 2019

Journal Articles

Cardiovascular (CV)-Related Hospitalizations and Associated Costs Among US Patients in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) in Routine Clinical Practice

Stuart L. Goldberg, MD, Michael J. Mauro, MD, Jorge E. Cortes, MD, Scott Justin Keating, MSc, BSc, Hitesh Bhandari, Clara Chen, PhD BS, MS

Blood (2019) 134 (Supplement_1): 4151.

https://doi.org/10.1182/blood-2019-128290

Published: 2019

Journal Articles

Live Immunization Practices for Chronically Transfused Pediatric Patients

Amanda Hogg, MD FRCPC, Susan Nahirniak, MD FRCPC, Wendy Vaudry, MD FRCPC, Aisha Bruce, MD

Blood (2017) 130 (Supplement 1): 3739.

https://doi.org/10.1182/blood.V130.Suppl_1.3739.3739

Published: 2017

Journal Articles

Published abstracts at international meetings often over- or underestimate the initial response rate

Ofrat Beyar-Katz, Jacob M. Rowe, Lauren E. Townsend, Martin S. Tallman, Rivka Hadomi, Netanel A. Horowitz

Blood (2017) 129 (16): 2326–2328.

https://doi.org/10.1182/blood-2017-01-763144

Published: 2017

Includes: Supplemental data

Journal Articles

Title: Progression-Free Survival 2 in Hematological Cancer Treatment Choices: Challenges to Routine Use

Angela Solaman, MHEcon, Andrew Walker, PhD, Faith E Davies, MD

Blood (2016) 128 (22): 5982.

https://doi.org/10.1182/blood.V128.22.5982.5982

Published: 2016

Journal Articles

Blood 's 70th anniversary: musings of a Blood editor, 2003-2007

Sanford J. Shattil

Blood (2016) 127 (22): 2649–2651.

https://doi.org/10.1182/blood-2015-11-635755

Published: 2016

Journal Articles

Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis

Alyssa Trenery, Samuel Kessler, BA, Van Slooten Eleasa, BS, Akida Lebby, Charles L. Bennett, MD, PhD, MPP, Paul Yarnold, PhD, Paul Ray, DO, MA, Dennis W. Raisch, PhD, MS, RPh, Gowtham Rao, MD, PhD, Peter Georgantopoulos, MPH, MA, LeAnne Norris, PharmD, Simone Boyle, BA, Ashlyn Byrne, Matthew Bialkowski, Oliver Sartor, MD

Blood (2013) 122 (21): 2938.

https://doi.org/10.1182/blood.V122.21.2938.2938

Published: 2013

Journal Articles

The ASH Clinical Research Training Institute (CRTI) Positively Impacts The Success Of Early Career Hematologists In Patient-Oriented Clinical Research

Linda J Burns, MD, Charles P Clayton, James N. George, MD, Beverly S. Mitchell, Scott D. Gitlin, MD

Blood (2013) 122 (21): 1679.

https://doi.org/10.1182/blood.V122.21.1679.1679

Published: 2013

Journal Articles

Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review

Annete Njue, PhD, Peter C Trask, PhD, MPH, Ann Colosia, PhD, Robert Olivares, MD, MSc, Shahnaz Khan, MPH, Adeline Abbe, MSc, Rachel Lee Police, MPH, Jianmin Wang, PhD, MD, Elizabeth Sherrill, MS, James A. Kaye, MD, DrPH, Farrukh T Awan, MD

Blood (2013) 122 (21): 5099.

https://doi.org/10.1182/blood.V122.21.5099.5099

Published: 2013

Journal Articles

Systems Biology to Predict Platelet Function

Scott L. Diamond, PhD

Blood (2010) 116 (21): SCI-38.

https://doi.org/10.1182/blood.V116.21.SCI-38.SCI-38

Published: 2010

Journal Articles

“Ghostbusting” at Blood

Cynthia E. Dunbar, Martin S. Tallman

Blood (2009) 113 (3): 502–503.

https://doi.org/10.1182/blood-2008-10-184952

Published: 2009

Journal Articles

A Budget Impact Model Comparing Resource Utilization of Four Approved Therapies for Multiple Myeloma (MM) in the US.

D.S. Pete Fullerton, Holly Trautman, Hui Huang, Jelena Veljkovic, Dixie-Lee Esseltine, Jing Marantz

Blood (2007) 110 (11): 3324.

https://doi.org/10.1182/blood.V110.11.3324.3324

Published: 2007

Journal Articles

The Predictive Value of a “Positive” ASH Abstract in AML Therapeutics.

Elihu H. Estey, MD, Slyva H. Bedikian, MS, Dianne C. Witter, Sherry A. Pierce, BA, Francis J. Giles, MD

Blood (2006) 108 (11): 1964.

https://doi.org/10.1182/blood.V108.11.1964.1964

Published: 2006

Journal Articles

Letter to authors and readers regarding the new NIH policy on public access

James N. George, MD, Sanford J. Shattil, MD

Blood (2005) 105 (10): 3767.

https://doi.org/10.1182/blood-2005-04-1396

Published: 2005

Journal Articles

Celebrate hematology

Kenneth Kaushansky, MD

Blood (2002) 100 (13): 4257–4258.

https://doi.org/10.1182/blood-2002-09-2984

Published: 2002

Journal Articles

“How I treat”: a new style of clinical review article

Kenneth Kaushansky, MD

Blood (2000) 96 (4): 1205.

https://doi.org/10.1182/blood.V96.4.1205

Published: 2000

Journal Articles

Evolution in BLOOD

Kenneth Kaushansky, MD

Blood (1999) 93 (5): 1441–1442.

https://doi.org/10.1182/blood.V93.5.1441

Published: 1999

NARROW

Contributions to Global Hematology from Low and Middle-Income Countries: Insights from ASH 2018

Cardiovascular (CV)-Related Hospitalizations and Associated Costs Among US Patients in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) in Routine Clinical Practice

Live Immunization Practices for Chronically Transfused Pediatric Patients

Published abstracts at international meetings often over- or underestimate the initial response rate

Title: Progression-Free Survival 2 in Hematological Cancer Treatment Choices: Challenges to Routine Use

Blood 's 70th anniversary: musings of a Blood editor, 2003-2007

Conflicts Of Interest In Pharmaceutical Sponsored Research On Erythropoietin Receptors In Cancer: An Updated Analysis

The ASH Clinical Research Training Institute (CRTI) Positively Impacts The Success Of Early Career Hematologists In Patient-Oriented Clinical Research

Efficacy and Safety Of Treatments For Relapsed Or Refractory Mantle Cell Lymphoma (MCL): Results Of a Systematic Literature Review

Systems Biology to Predict Platelet Function

“Ghostbusting” at Blood

A Budget Impact Model Comparing Resource Utilization of Four Approved Therapies for Multiple Myeloma (MM) in the US.

The Predictive Value of a “Positive” ASH Abstract in AML Therapeutics.

Letter to authors and readers regarding the new NIH policy on public access

Celebrate hematology

“How I treat”: a new style of clinical review article

Evolution in BLOOD

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only